SERA
vs
U
USBC
SERA
Over the past 12 months, SERA has underperformed USBC, delivering a return of -52% compared to the USBC's +500 400% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
SERA
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Sera Prognostics Inc
NASDAQ:SERA
|
3.01
USD
|
|||||
|
U
|
US BioTec Inc
OTC:USBC
|
0.5005
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
SERA, USBC
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Sera Prognostics Inc
Revenue
|
|||||||||||
|
U
|
US BioTec Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
SERA, USBC
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Sera Prognostics Inc
NASDAQ:SERA
|
|||||||||
|
U
|
US BioTec Inc
OTC:USBC
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Sera Prognostics Inc | ||||
|
U
|
US BioTec Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
SERA, USBC
Performance Gap
SERA, USBC
Performance By Year
SERA, USBC
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
